| C. albican | Candida albicans |
| COX-2 | Cyclooxygenase-2 |
| DGL | Deglycyrrhiznated licorice |
| DPPH | 2,2-diphenyl-1-picryl-hydrazyl-hydrate |
| EBV | Epstein-Barr virus |
| E. faecalis | Enterococcus faecalis |
| FDA | Food and Drug Administration |
| GA | 18-β-glycyrrhetinic acid |
| G. glabra | Glycyrrhiza glabra L. |
| GL | Glycyrrhizic acid |
| HCV | Hepatitis C virus |
| HMGBI | High mobility group box 1 protein |
| HSV | Herpes simplex virus |
| ISL | Isoliquiritigenin |
| KSA | Kingdom od Saudi Arabia |
| MMPs | Matrix metalloproteinases |
| OLP | Oral lichen planus |
| OSCC | Oral Squamous Cell Carcinoma |
| OSF | Oral submucous fibrosis |
| P. gingivalis | Porphyromonas gingivalis |
| PGE2 | Prostaglandin E2 |
| RCT | Randomised controlled trial |
| ROS | Reactive oxygen species |
| SNMC | Stronger Neo-Minophagen C |
| TNF | Tumour necrosis factor |
| WHO | World Health Organisation |